Calcium Release Deficiency Syndrome (CRDS)

1

Review clinical trials related to Calcium Release Deficiency Syndrome (CRDS). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Evaluation of A Clinical Diagnostic Test for CRDS

Calcium Release Deficiency Syndrome (CRDS) is a novel inherited arrhythmia syndrome secondary to RyR2 loss-of-function that confers a risk of sudden cardiac death. Diagnosis of CRDS presently requires cellular-based in vitro confirmation that an RyR2 variant causes loss-of-function. We hypothesize that CRDS can be diagnosed clinically through evaluation of the repolarization response to brief tachycardia, mediated by cardiac pacing, and a subsequent pause.

Participants needed: 400
Trial details
Biological sex: AllType: InterventionalSponsor: Population Health Research InstituteUpdated: Jun 1, 2026Locations: 19
Eligibility criteria

Satisfy a clinical phenotype consistent with the Expert Consensus Statement [+15]